US agency fast-tracks Ebola vaccine development
Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’
Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’